Arkolith/Insider Trading/VYGR/Form 4

Carter Todd Alfred

Chief Scientific OfficerVoyager Therapeutics, Inc. (VYGR) · full profile →Form 4 · filed Feb 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11K
Net Open-Market Flow
-$11K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 18, 2026Sell(S)3K$3.44$11K150K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-26-018130) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML